Identification of stem-like cells in non-small cell lung cancer cells with specific peptides

Cancer Letters

Volumn 351, Issue 1, 2014, Pages 100-107

  Wang, Anxin ^a,b,c   Chen, Lisha ^a,b,c   Pu, Kefeng ^a,b,c   Zhu, Yimin ^a  

^a SUZHOU INSTITUTE OF NANO TECH AND NANO BIONICS   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Bacterial surface display; Cancer stem like cells; MicroRNA; Peptide; Tumor spheres

Indexed keywords

HCBP 1 PEPTIDE; MICRORNA; POLYPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL SURFACE DISPLAY METHOD; BINDING AFFINITY; BINDING SITE; CANCER STEM CELL; CELL ASSAY; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; LUNG NON SMALL CELL CANCER; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BINDING;

BACTERIA (MICROORGANISMS);

BACTERIAL SURFACE DISPLAY; CANCER STEM-LIKE CELLS; MICRORNA; PEPTIDE; TUMOR SPHERES;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASTIC STEM CELLS; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PROTEIN BINDING; SPHEROIDS, CELLULAR; STAINING AND LABELING; TRANSCRIPTOME;

EID: 84903726105     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.05.004     Document Type: Article

References (38)

1. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
2. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
3. Shackleton M., Quintana E., Fearon E.R., Morrison S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-829.
4. Valent P., Bonnet D., De Maria R., Lapidot T., Copland M., Melo J.V., Chomienne C., Ishikawa F., Schuringa J.J., Stassi G., Huntly B., Herrmann H., Soulier J., Roesch A., Schuurhuis G.J., Wohrer S., Arock M., Zuber J., Cerny-Reiterer S., Johnsen H.E., Andreeff M., Eaves C. Cancer stem cell definitions and terminology: the devil is in the details. Nat. Rev. Cancer 2012, 12:767-775.
5. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15:504-514.
6. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
7. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
8. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., Bray R.A., Waller E.K., Buck D.W. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90:5013-5021.
9. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456. 593-U533.
10. Shmelkov S.V., Butler J.M., Hooper A.T., Hormigo A., Kushner J., Milde T., Clair R.S., Baljevic M., White I., Jin D.K. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J. Clin. Investig. 2008, 118:2111.
11. Zhang W.C., Shyh-Chang N., Yang H., Rai A., Umashankar S., Ma S.M., Soh B.S., Sun L.L., Tai B.C., Nga M.E., Bhakoo K.K., Jayapal S.R., Nichane M., Yu Q., Ahmed D.A., Tan C., Sing W.P., Tam J., Thirugananam A., Noghabi M.S., Pang Y.H., Ang H.S., Robson P., Kaldis P., Soo R.A., Swarup S., Lim E.H., Lim B. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 2012, 148:259-272.
12. Ho M.M., Ng A.V., Lam S., Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007, 67:4827-4833.
13. Jiang F., Qiu Q., Khanna A., Todd N.W., Deepak J., Xing L.X., Wang H.J., Liu Z.Q., Su Y., Stass S.A., Katz R.L. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol. Cancer Res. 2009, 7:330-338.
14. Akunuru S., Zhai Q.J., Zheng Y. Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell Death Dis. 2012, 3:e352.
15. Honoki K., Fujii H., Kubo A., Kido A., Mori T., Tanaka Y., Tsujiuchi T. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol. Rep. 2010, 24:501-505.
16. Vermeulen L., Todaro M., Mello F.D., Sprick M.R., Kemper K., Alea M.P., Richel D.J., Stassi G., Medema J.P. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 2008, 105:13427-13432.
17. Dane K.Y., Chan L.A., Rice J.J., Daugherty P.S. Isolation of cell specific peptide ligands using fluorescent bacterial display libraries. J. Immunol. Methods 2006, 309:120-129.
18. Dong B., Wang A.X., Yuan L.H., Chen L.S., Pu K.F., Duan W., Yan X.Y., Zhu Y.M. Peptide-fluorescent bacteria complex as luminescent reagents for cancer diagnosis. PLoS ONE 2013, 8:e54467.
19. Feng S.P., Cong S.J., Zhang X., Bao X.C., Wang W., Li H.P., Wang Z., Wang G.X., Xu J.Z., Du B.W., Qu D.Z., Xiong W., Yin M.H., Ren X.S., Wang F.F., He J.X., Zhang B.L. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res. 2011, 39:6669-6678.
20. Qu D.Z., Wang G.X., Wang Z., Zhou L., Chi W.L., Cong S.J., Ren X.S., Liang P.Z., Zhang B.L. 5-Ethynyl-2 '-deoxycytidine as a new agent for DNA labeling: Detection of proliferating cells. Anal. Biochem. 2011, 417:112-121.
21. Qu D.Z., Zhou L., Wang W., Wang Z., Wang G.X., Chi W.L., Zhang B.L. 5-Ethynylcytidine as a new agent for detecting RNA synthesis in live cells by "click" chemistry. Anal. Biochem. 2013, 434:128-135.
22. Yang X., Zhang M., Yang B., Zhang H., Zhang Y. Isolation, culture, identification, frozenness and thaw of mesenchymal stem cells from Wharton's jelly of human umbilical cord. J. Nantong Univ. (Med. Sci.) 2010, 6:413-415.
23. Benedict C.A., MacKrell A.J., Anderson W.F. Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay. J. Immunol. Methods 1997, 201:223-231.
24. Duan D.M., Zheng K.X., Shen Y., Cao R., Jiang L., Lu Z.X., Yan X.Y., Li J. Label-free high-throughput microRNA expression profiling from total RNA. Nucleic Acids Res. 2011, 39:e154.
25. Chen C.F., Ridzon D.A., Broomer A.J., Zhou Z.H., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R., Lao K.Q., Livak K.J., Guegler K.J. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33:e179.
26. Benitah S.A. TUMOUR BIOLOGY Skin-cancer stem cells outwitted. Nature 2011, 478:329-330.
27. Goel H.L., Mercurio A.M. VEGF targets the tumour cell. Nat. Rev. Cancer 2013, 13:871-882.
28. Levina V., Marrangoni A.M., DeMarco R., Gorelik E., Lokshin A.E. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. Plos One 2008, 3:e3077.
29. Bertolini G., Roz L., Perego P., Tortoreto M., Fontanella E., Gatti L., Pratesi G., Fabbri A., Andriani F., Tinelli S., Roz E., Caserini R., Lo Vullo S., Camerini T., Mariani L., Delia D., Calabro E., Pastorino U., Sozzi G. Highly tumorigenic lung cancer CD133(+) cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. USA 2009, 106:16281-16286.
30. Miao Y.J., Li J.Y., Qiu X.F., Li Y.L., Wang Z.Y., Luan Y.J. MiR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro. Oncol. Rep. 2013, 29:161-168.
31. Zhang J.G., Wang J.J., Zhao F., Liu Q., Jiang K., Yang G.H. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin. Chim. Acta 2010, 411:846-852.
32. Liu S.L., Clouthier S.G., Wicha M.S. Role of microRNAs in the regulation of breast cancer stem cells. J. Mammary Gland Biol. 2012, 17:15-21.
33. Liu C., Kelnar K., Vlassov A.V., Brown D., Wang J.C., Tang D.G. Distinct microRNA Expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res. 2012, 72:3393-3404.
34. DeSano J.T., Xu L. MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J. 2009, 11:682-692.
35. Si M.L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.Y. MiR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
36. Jiang L.L., Huang Q., Chang J.H., Wang E.H., Qiu X.S. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp. Lung Res. 2011, 37:387-398.
37. Linsley P.S., Schelter J., Burchard J., Kibukawa M., Martin M.M., Bartz S.R., Johnson J.M., Cummins J.M., Raymond C.K., Dai H.Y., Chau N., Cleary M., Jackson A.L., Carleton M., Lim L. Transcripts targeted by the MicroRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell Biol. 2007, 27:2240-2252.
38. Hu R., Liu W., Li H., Yang L., Chen C., Xia Z.Y., Guo L.J., Xie H., Zhou H.D., Wu X.P., Luo X.H. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J. Biol. Chem. 2011, 286:12328-12339.